Education
About Us
Working with TipRanks
Follow Us
Newton Charles W. Insider Profile
11 Followers
Newton Charles W., CFO at Lyell Immunopharma, holds 25.31K shares in Lyell Immunopharma (Ticker: LYEL), holds ― shares in Coherus Biosciences (Ticker: CHRS), holds 22.63K shares in 2seventy bio (Ticker: TSVT).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+4.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Newton Charles W. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Newton Charles W.
Newton Charles W.'s Trading History
Lyell Immunopharma
Aug 22, 2025
CFO
Uninformative Buy
―
$280.90K
Coherus Biosciences
―
Director
―
―
2seventy bio
Jun 12, 2024
―
Uninformative Buy
―
$113.13K
Novavax
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Newton Charles W.'s performance on stock
You May Also Like
Newton Charles W. insider profile FAQ
What is the percentage of profitable transactions made by Newton Charles W.?
The percentage of profitable transactions made by Newton Charles W. is 67%.
What is the average return per transaction made by Newton Charles W.?
The average return per transaction made by Newton Charles W. is 4.10%.
What stocks does Newton Charles W. hold?
Newton Charles W. holds: LYEL, CHRS, TSVT, NVAX stocks.
What was Newton Charles W.’s latest transaction?
Newton Charles W. latest transaction was an Uninformative Buy of ―.
What was Newton Charles W.'s most profitable transaction?
Newton Charles W.’s most profitable transaction was an Informative Buy of LYEL stock on March 18, 2025. The return on the trade was 11.90%.
What is Newton Charles W.'s role in Lyell Immunopharma?
Newton Charles W.'s role in Lyell Immunopharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.